Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Looked at a 21 day "whether forecast", The "wins of change"

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon Feb 17, 2021 4:51pm

166 Views

Post# 32587965

RE:RE:RE:Looked at a 21 day "whether forecast", The "wins of change"

Domino55 wrote: MM-can you elaborate on the Liquid Conditions you are projecting?

do you think we will have word soon on what their US listing plans are. I think that announcement may come soon after Dr Kellum comes aboard.

No I can't.

And Yes (if by soon you mean 6 mo or less)

Call it a feeling ...on both counts.

MM

<< Previous

Bullboard Posts

Next >>

Stockhouse DealRoom opens new Australian opportunities